MedPath

Tuberculosis Research Blood Bank

Withdrawn
Conditions
Tuberculosis
Interventions
Procedure: Develop a bank of blood samples from patients infected with TB for future molecular genetics studies and serological studies
Registration Number
NCT00212498
Lead Sponsor
NYU Langone Health
Brief Summary

To create a Tuberculosis Research Blood Bank for future molecular genetics and serological studies

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • TB suspect with positive sputum smear
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
TB diagnosisDevelop a bank of blood samples from patients infected with TB for future molecular genetics studies and serological studies-
Primary Outcome Measures
NameTimeMethod
Develop TB Blood BankLong-Term

To develop a bank of blood samples (serum, plasma, buffy coat DNA) and urine from patients infected with TB. This blood and urine will be used for future molecular genetics studies. Demographic data will be collected and samples will be stored by number. The banked specimens will be evaluated in an attempt to identify susceptibility genes in TB disease. Specifically, expression of the human Bcg gene that codes for resistance to M. tuberculosis will be evaluated and its expression correlated expression with gender, race, clinical TB characteristics. Each patient will have a unique identifier and therefore data generated from this analysis will not be linkable to the patient.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

NYU School of Medicine Division of Pulmonary and Critical Care Medicine

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath